CClinicalTrials.gg
Status unknownNCT05491291VALRESCICUpdated Aug 8, 2022

Chronic Wound Care of Lower Limb in M@diCICAT Center at CHU de Martinique

An interventional study of Patients with chronic wound of the lower limbs in Chronic Wounds, sponsored by University Hospital Center of Martinique. Status unknown at 1 site in Martinique. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-08-08.

Sponsored by University Hospital Center of Martinique · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Aug 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Chronic wound of lower limb. In developed countries, the prevalence of chronic wounds is linked to the ageing of the population and the increase in chronic diseases such as diabetes, obesity and cardiovascular disease. Consequence: amputations of lower limb. The prevalence of chronic wounds is also variable across the globe. In addition, chronic wounds are associated with psychosocial problems such as poor quality of life, loss of professional activity and progressive de-socialization of patients. To improve the quality of care we need in french wound assessment tools validated scientifically like the RESVECH 2.0 scale, validated in the Spanish language.

Read the detailed description

The VALRESCIC study aims to perform a cross-cultural and psychometric validation of the RESVECH 2.0 scale in order to be able to use it for monitoring wounds in both hospital and primary care settings in the French West Indies.

The RESVECH 2.0 scale is a heterogeneous scale to monitor the evolution of a chronic wound. This scale was created in 2010 and consists of 6 items with response modalities ranging from 5 to 14. The interpretation of the scale parameters may differ depending on the cultural context. The RESVECH 2.0 scale has been validated in the Spanish language (in Spain and Colombia) to assess the progress towards healing of pressure ulcers and chronic wounds of the lower limbs.

For the cross-cultural evaluation we will follow Beaton's methodology, which includes: translation, synthesis, retro-translation, expert committee review and pre-testing. For the psychometric validation, the following parameters will be measured: Feasibility and acceptability, validity, reliability, and sensitivity to change.

02

Conditions studied

  • Chronic Wounds

Browse trials for

Keywords

  • Chronic wounds
  • RESVECH 2.0
  • Wound assesment tool
  • cross-cultural validation,
03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.

This study's planned enrollment of 120 is above the median of 52 across 3,239 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

University Hospital Center of Martinique is the lead sponsor of 77 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with at least one chronic wound of the lower limbs admitted to the M@diCICAT® healing centre.
  • Patients agreeing to participate in the study
  • Patients affiliated to a social security scheme

Exclusion criteria

Exclusion Criteria:

  • Patients with critical ischemia of the lower limb concerned
  • Patients under legal protection measures (guardianship, curatorship, safeguard of justice) and persons deprived of liberty
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Other
    Patients with chronic wound of the lower limbs

    Passing of the scale when the patient will come at the hospital for his routine health care visit in M@diCICAT center

    Other: Patients with chronic wound of the lower limbs

Interventions

  • OtherPatients with chronic wound of the lower limbs

    The rating scale will be passed at three different times, day 1, day 15 and day 75.

06

What researchers measure

Primary outcomes

  1. Cultural adaptation of the RESVECH 2.0 scale.

    Validation of scale RESVECH 2.0 translation in french language depending on the cultural context in French West Indies

    Time frame: Before the start of recruitment

  2. Psychometric validation of the RESVECH 2.0 scale.

    Scientific validation of the french version of the scale RESVECH 2.0 in French West Indies

    Time frame: 15 days post inclusion

07

Study locations

1 site
08

References and documents

Publications

  • Alvarez-Del-Rio RF. Factors Associated to the Cicatrization Success of Lower-Limb Ulcer of Venous Etiology. Invest Educ Enferm. 2018 Sep;36(3). doi: 10.17533/udea.iee.v36n3e08. PubMed 31083854 ↗
  • Aragon-Sanchez J, Lipsky BA, Lazaro-Martinez JL. Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients? Diabet Med. 2011 Feb;28(2):191-4. doi: 10.1111/j.1464-5491.2010.03150.x. PubMed 21219428 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05491291
Lead sponsor
University Hospital Center of Martinique
Responsible party
Sponsor
First posted
Aug 8, 2022
Start date
Nov 2022 (estimated)
Primary completion
May 2024 (estimated)
Completion
Aug 2024 (estimated)
Last update
Aug 8, 2022

Study contacts

Jocelyne CRASPAG, MSc
Contact
jocelyne.craspag@chu-martinique.fr
0596592698 ext. +596
Maria CANO SANCHEZ, RN
Contact
maria.canosanchez@chu-martinque.fr
0596553545 ext. +596
Maria CANO SANCHEZ, RN
study director · CHU de Martinique

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion